The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Atherosclerosis, which is the most common chronic disease of the coronary artery, constitutes a vascular pathology induced by inflammation and plaque accumulation within arterial vessel walls. Both DNA methylation and histone modifications are epigenetic changes relevant for atherosclerosis. Recent studies have shown that the DNA methylation and histone modification systems are closely interrelated and mechanically dependent on each other. Herein, we explore the functional linkage between these systems, with a particular emphasis on several recent findings suggesting that histone acetylation can help in targeting DNA methylation and that DNA methylation may control gene expression during atherosclerosis.
Abstract
Atherosclerosis, which is the most common chronic disease of the coronary artery, constitutes a vascular pathology induced by inflammation and plaque accumulation within arterial vessel walls. Both DNA methylation and histone modifications are epigenetic changes relevant for atherosclerosis. Recent studies have shown that the DNA methylation and histone modification systems are closely interrelated and mechanically dependent on each other. Herein, we explore the functional linkage between these systems, with a particular emphasis on several recent findings suggesting that histone acetylation can help in targeting DNA methylation and that DNA methylation may control gene expression during atherosclerosis.
참고문헌 (80)
- Libby P, "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2002)
- Tabas I, "Recent insights into the cellular biology of atherosclerosis", J Cell Biol, 209, pp.13~22 (2015)
- Chistiakov DA, "Mechanisms of foam cell formation in atherosclerosis", J Mol Med(Berl), 95, pp.1153~1165 (2017)
- Bianchi M, "Coordinated actions of microRNAs with other epigenetic factors regulate skeletal muscle development and adaptation", Int J Mol Sci, 18, pp.840~ (2017)
- Brown JD, "NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis", Mol Cell, 56, pp.219~231 (2014)
- Zaina S, "DNA methylation map of human atherosclerosis", Circ Cardiovasc Genet, 7, pp.692~700 (2014)
- Khyzha N, "Epigenetics of atherosclerosis : emerging mechanisms and methods", Trends Mol Med, 23, pp.332~347 (2017)
- Curradi M, "Molecular mechanisms of gene silencing mediated by DNA methylation", Mol Cell Biol, 22, pp.3157~3173 (2002)
- Watson JD, "Molecular biology of the gene" (2004), Pearson Higher Ed USA
- Comb M, "CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2", Nucleic Acids Res, 18, pp.3975~3982 (1990)
- Prendergast GC, "Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation", Cell, 65, pp.395~407 (1991)
- Iguchi-Ariga SM, "CpG methylation of the cAMP-responsive enhancer", promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation, 1989, pp.3, 612~619
- Falzon M, "Binding of the transcription factor EBP-80 mediates the methylation response of an intracisternal A-particle long terminal repeat promoter", Mol Cell Biol, 11, pp.117~125 (1991)
- Kovesdi I, "Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control", Proc Natl Acad Sci U S A, 84, pp.2180~2184 (1987)
- Inamdar NM, "CpG methylation inhibits binding of several sequence-specific DNA-binding proteins from pea, wheat, soybean and cauliflower", Plant Mol Biol, 17, pp.111~123 (1991)
- Ehrlich KC, "A broad bean cDNA clone encoding a DNA-binding protein resembling mammalian CREB in its sequence specificity and DNA methylation sensitivity", Gene, 117, pp.169~178 (1992)
- Nan X, "Gene silencing by methyl-CpG-binding proteins", Novartis Found Symp, 214, pp.6~16 (1998)
- Boyes J, "DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein", Cell, 64, pp.1123~1134 (1991)
- Meehan RR, "DNA methylation and control of gene expression in vertebrate development", Essays Biochem, 37, pp.59~70 (2001)
- Kohli RM, "TET enzymes, TDG and the dynamics of DNA demethylation", Nature, 502, pp.472~479 (2013)
- Bhattacharya SK, "A mammalian protein with specific demethylase activity for mCpG DNA", Nature, 397, pp.579~583 (1999)
- Ng HH, "MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex", Nat Genet, 23, pp.58~61 (1999)
- Hendrich B, "Identification and characterization of a family of mammalian methyl-CpG binding proteins", Mol Cell Biol, 18, pp.6538~6547 (1998)
- Sancar A, "Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints", Annu Rev Biochem, 73, pp.39~85 (2004)
- Zhu JK, "Active DNA demethylation mediated by DNA glycosylases", Annu Rev Genet, 43, pp.143~166 (2009)
- Choi Y, "DEMETER, a DNA glycosylase domain protein, is required for endosperm gene imprinting and seed viability in arabidopsis", Cell, 110, pp.33~42 (2002)
- Navaratnam N, "The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase", J Biol Chem, 268, pp.20709~20712 (1993)
- Teng B, "Molecular cloning of an apolipoprotein B messenger RNA editing protein", Science, 260, pp.1816~1819 (1993)
- Muramatsu M, "Class switch recombination and hypermutation require activation-induced cytidine deaminase(AID), a potential RNA editing enzyme", Cell, 102, pp.553~563 (2000)
- Revy P, "Activation-induced cytidine deaminase(AID)deficiency causes the autosomal recessive form of the Hyper-IgM syndrome(HIGM2)", Cell, 102, pp.565~575 (2000)
- Tahiliani M, "Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1", Science, 324, pp.930~935 (2009)
- Ito S, "Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification", Nature, 466, pp.1129~1133 (2010)
- Ko M, "Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX", Nature, 497, pp.122~126 (2013)
- Ficz G, "Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation", Nature, 473, pp.398~402 (2011)
- Stadler MB, "DNA-binding factors shape the mouse methylome at distal regulatory regions", Nature, 480, pp.490~495 (2011)
- Moore LD, "DNA methylation and its basic function", Neuropsychopharmacology, 38, pp.23~38 (2013)
- Marmorstein R, "Histone acetyltransferases : function, structure, and catalysis", Curr Opin Genet Dev, 11, pp.155~161 (2001)
- Song CX, "Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming", Cell, 153, pp.678~691 (2013)
- Bird AP, "Methylation-induced repression--belts, braces, and chromatin", Cell, 99, pp.451~454 (1999)
- Szyf M, "Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle", Proc Natl Acad Sci U S A, 82, pp.8090~8094 (1985)
- Cervoni N, "Demethylase activity is directed by histone acetylation", J Biol Chem, 276, pp.40778~40787 (2001)
- Chen YC, "Atherosclerotic plaque rupture : identifying the straw that breaks the camel's back", Arterioscler Thromb Vasc Biol, 36, pp.e63~ (2016)
- Libby P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
- Hansson GK, "Inflammation and atherosclerosis", Annu Rev Pathol, 1, pp.297~329 (2006)
- Herrero-Fernandez B, "Immunobiology of atherosclerosis : a complex net of interactions", Int J Mol Sci, 20, pp.5293~ (2019)
- Stenvinkel P, "Impact of inflammation on epigenetic DNA methylation-a novel risk factor for cardiovascular disease?", J Intern Med, 261, pp.488~499 (2007)
- Sharma P, "Detection of altered global DNA methylation in coronary artery disease patients", DNA Cell Biol, 27, pp.357~365 (2008)
- Gimbrone MA Jr, "Endothelial cell dysfunction and the pathobiology of atherosclerosis", Circ Res, 118, pp.620~636 (2016)
- Chiu JJ, "Effects of disturbed flow on vascular endothelium : pathophysiological basis and clinical perspectives", Physiol Rev, 91, pp.327~387 (2011)
- Zhou J, "Shear stress-initiated signaling and its regulation of endothelial function", Arterioscler Thromb Vasc Biol, 34, pp.2191~2198 (2014)
- Dunn J, "Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis", J Clin Invest, 124, pp.3187~3199 (2014)
- Zhang YP, "The mammalian target of rapamycin and DNA methyltransferase 1 axis mediates vascular endothelial dysfunction in response to disturbed flow", Sci Rep, 7, pp.14996~ (2017)
- Yu J, "DNMT1-PPARγ pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice", Sci Rep, 6, pp.30053~ (2016)
- Singh KK, "BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis", Thorac Cardiovasc Surg, 146, pp.949~960 (2013)
- Istas G, "Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease", Sci Rep, 7, pp.5120~ (2017)
- Peng J, "Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-", -mice, 2016, pp.7, 76423~76436
- Lee DY, "A positive role for histone acetylation in transcription factor access to nucleosomal DNA", Cell, 72, pp.73~84 (1993)
- Stasevich TJ, "Regulation of RNA polymerase II activation by histone acetylation in single living cells", Nature, 516, pp.272~275 (2014)
- Kaimori JY, "Histone H4 lysine 20 acetylation is associated with gene repression in human cells", Sci Rep, 6, pp.24318~ (2016)
- Xhemalce B, "A chromodomain switch mediated by histone H3 Lys 4 acetylation regulates heterochromatin assembly", Genes Dev, 24, pp.647~652 (2010)
- Dje N'Guessan P, "Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells", Arterioscler Thromb Vasc Biol, 29, pp.380~386 (2009)
- Jongstra-Bilen J, "Oxidized low-density lipoprotein loading of macrophages downregulates TLR-induced proinflammatory responses in a gene-specific and temporal manner through transcriptional control", J Immunol, 199, pp.2149~2157 (2017)
- Choi JH, "Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice", Arterioscler Thromb Vasc Biol, 25, pp.2404~2409 (2005)
- Greißel A, "Histone acetylation and methylation significantly change with severity of atherosclerosis in human carotid plaques", Cardiovasc Pathol, 25, pp.79~86 (2016)
- Sahar S, "Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells", Arterioscler Thromb Vasc Biol, 27, pp.1528~1534 (2007)
- Vlad ML, "Histone acetyltransferase-dependent pathways mediate upregulation of NADPH oxidase 5 in human macrophages under inflammatory conditions : a potential mechanism of reactive oxygen species overproduction in atherosclerosis", Oxid Med Cell Longev, 2019, pp.3201062~ (2019)
- Okamoto H, "Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1)", J Atheroscler Thromb, 13, pp.183~191 (2006)
- Nencioni A, "Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity", Clin Cancer Res, 13, pp.3933~3941 (2007)
- Findeisen HM, "Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition", Arterioscler Thromb Vasc Biol, 31, pp.851~860 (2011)
- Zhao Q, "miR-34a targets HDAC1-regulated H3K9 acetylation on lipid accumulation induced by homocysteine in foam cells", J Cell Biochem, 118, pp.4617~4627 (2017)
- Ye S, "Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease", Eur Heart J, 24, pp.1668~1671 (2003)
- Galis ZS, "Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques", J Clin Invest, 94, pp.2493~2503 (1994)
- Kim MK, "The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription", PLoS One, 4, pp.e4864~ (2009)
- Ujfaludi Z, "Coordinated activation of a cluster of MMP genes in response to UVB radiation", Sci Rep, 8, pp.2660~ (2018)
- Rodríguez-Salvador J, "Effect of sodium butyrate on pro-matrix metalloproteinase-9 and-2 differential secretion in pediatric tumors and cell lines", J Exp Clin Cancer Res, 24, pp.463~473 (2005)
- Lenglet S, "Role of matrix metalloproteinase-8 in atherosclerosis", Mediators Inflamm, 2013, pp.659282~ (2013)
- Newby AC, "Metalloproteinases promote plaque rupture and myocardial infarction : a persuasive concept waiting for clinical translation", Matrix Biol (2015)
- Young DA, "Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption", Arthritis Res Ther, 7, pp.R503~ (2005)
- Hoeksema MA, "Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions", EMBO Mol Med, 6, pp.1124~1132 (2014)
- Cao Q, "Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development", Arterioscler Thromb Vasc Biol, 34, pp.1871~1879 (2014)
